Aptamers Engineered Nanocarriers for Cancer Therapy

Aptamers Engineered Nanocarriers for Cancer Therapy is a book that discusses the use of aptamer-based nano agents for cancer therapeutics, including their selection technologies, biological characteristics, and clinical uses. It provides insights into the challenges of manufacturing nano-aptamers and highlights the potential of aptamers as anticancer therapies.

Format: Paperback / softback
Length: 556 pages
Publication date: 01 October 2022
Publisher: Elsevier Science Publishing Co Inc

Aptamers Engineered Nanocarriers for Cancer Therapy delves into the intricate realm of aptamer-based nano agents, exploring their selection technologies, biological properties, and clinical applications in cancer therapeutics. This comprehensive resource serves as a valuable tool in expediting solutions to various challenges associated with nano-aptamer manufacture, including toxicity, thermal stability, cost-effectiveness, tumor penetration, and blood stability. Key chapters delve into cell-SELEX technology for aptamer selection, mechanisms of multi-drug resistance in cancer, the significance of aptamers as anticancer therapies, and the diverse range of aptamer-functionalized nanostructures available. This book offers captivating insights into this relatively novel approach to cancer therapeutics, appealing to materials scientists, biomedical engineers, molecular biologists, biochemists, and clinical scientists with a special emphasis on cancer therapy.

Introduction:
Aptamers, short nucleic acid strands, have emerged as powerful tools in the field of medicine due to their unique properties. They can bind to a wide range of targets with high specificity and affinity, making them ideal candidates for various therapeutic applications. In recent years, aptamer-based nanocarriers have gained significant attention as a promising approach for cancer therapy. These nanocarriers are designed to deliver therapeutic agents specifically to cancer cells, enhancing their effectiveness and reducing side effects.
Selection Technologies:
Aptamer selection is a critical step in the development of aptamer-based nanocarriers. Various selection technologies, such as cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment), have been developed to isolate aptamers that bind to cancer cells. Cell-SELEX involves the selection of aptamers from a library of nucleic acids, which are then exposed to cells that express specific targets. The aptamers that bind to the target cells are amplified and selected for further characterization.
Biological Characteristics:
Aptamers possess several biological characteristics that make them suitable for cancer therapy. They are highly stable, can withstand harsh environmental conditions, and can penetrate cell membranes. Aptamers can also be modified to enhance their biological properties, such as targeting specific cancer cells or improving their stability in the bloodstream.
Clinical Uses:
Aptamer-based nanocarriers have shown promising results in clinical trials for cancer therapy. They have been used to deliver therapeutic agents, such as drugs, genes, and antibodies, to cancer cells. Aptamer-based nanocarriers can improve the targeting of cancer cells, reduce drug resistance, and increase the effectiveness of cancer treatments.
Challenges:
Despite their potential benefits, aptamer-based nanocarriers face several challenges. One of the major challenges is the stability of the nanocarriers in the bloodstream. Aptamers are susceptible to degradation by enzymes and other biological molecules, which can reduce their effectiveness and increase the risk of side effects.
Future Directions:
To overcome these challenges, researchers are exploring various strategies to improve the stability and effectiveness of aptamer-based nanocarriers. One approach is to modify the nanocarrier's surface properties to prevent degradation and enhance their circulation time. Another approach is to develop new nanocarrier materials that are more resistant to biological degradation.
Conclusion:
Aptamers Engineered Nanocarriers for Cancer Therapy provides a comprehensive overview of aptamer-based nano agents for cancer therapy. It highlights the selection technologies, biological characteristics, and clinical applications of aptamer-based nanocarriers. This book serves as a valuable resource for materials scientists, biomedical engineers, molecular biologists, biochemists, and clinical scientists with a focus on cancer therapy. By exploring the potential of aptamer-based nanocarriers, we can hope to develop more effective and targeted cancer treatments in the future.

Dimension: 229 x 152 (mm)
ISBN-13: 9780323858816